Topic resource collection
Approved comparison material connected to this topic.
5 resourcesRead both sides
Selective androgen receptor modulators (SARMs) and growth hormone secretagogues are often conflated in research discussions, but their mechanisms are fundamentally different. SARMs bind androgen receptors directly. Mimicking test…
CJC-1295 with DAC GHRH receptor agonist with albumin binding 2mg weekly subcutaneous 8 days Indirect. Restores pulsatile GH → LH normalisation → testosterone synthesis Extended half-life allows weekly dosing; preserves natural GH…
| Compound | Primary Mechanism | HPG Axis Impact | Typical Research Dose | Time to Measurable Effect | Recovery After Cessation | Professional Assessment ||—|—|—|—|—|—|| Gonadorelin | GnRH receptor agonist. Stimulates LH/FSH rele…
MK 677 (Ibutamoren) Ghrelin receptor agonist. Stimulates continuous GH release 12.5–25mg daily Once daily (oral or subcutaneous) 15–25% increase in free testosterone over 8–12 weeks in clinical trials Best for sustained GH elevat…
Your testosterone is governed by the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. GnRH tells the pituitary to release luteinizing hormone (LH), and LH tells…